Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correlation between resumption of employment and overall survival following awake mapping-based surgery for IDH-mutant grade 2 glioma: a consecutive series with 515 patients.

Journal of neurosurgery·2026

Same author

The future of neurosurgical oncology lies in cognitive neurosciences: understanding brain processing is much more valuable than surgical technology.

Frontiers in oncology·2026

Same author

What is the actual role of intraoperative MRI on long-term onco-functional outcome of surgery for low-grade glioma? A systematic review.

Journal of neuro-oncology·2026

Same author

Intractable epilepsy before and/or after awake functional mapping-based surgery for IDH-mutant grade 2 glioma: a consecutive series of 105 patients.

Journal of neurosurgery·2026

Same author

Individualized multiparadigm mapping and standardized tablet-based task administration during awake craniotomy: associations with return to work and survival in diffuse gliomas.

Journal of neurosurgery·2026

Same author

EDNRB-dependent endothelin signaling reduces proliferation and promotes proneural-to-mesenchymal transition in gliomas.

Molecular oncology·2026

Search research articles

Related Experiment Video

Updated: Mar 8, 2026

Stereotactic Intracranial Implantation and In vivo Bioluminescent Imaging of Tumor Xenografts in a Mouse Model System of Glioblastoma Multiforme

Stereotactic Intracranial Implantation and In vivo Bioluminescent Imaging of Tumor Xenografts in a Mouse Model System of Glioblastoma Multiforme

Published on: September 25, 2012

[Glioblastoma in 2017].

Hugues Duffau¹

¹Hôpital Gui de Chauliac, CHU de Montpellier, 80 avenue Augustin-Fliche, 34 000 Montpellier, France; INSERM U1051, Institut des neurosciences de Montpellier, Hôpital Saint Eloi, CHU de Montpellier, 80 avenue Augustin-Fliche, 34 000 Montpellier, France.

Revue De L'Infirmiere

|February 6, 2017

Summary

Glioblastomas are aggressive brain tumors with poor prognosis. Treatment involves surgery, radiotherapy, and chemotherapy to extend survival and maintain quality of life through supportive care.

Keywords:

biopsie biopsy chemotherapy chimiothérapie excision exérèse glioblastoma glioblastome radiotherapy radiothérapie soins de support supportive care

More Related Videos

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

Laboratory-Engineered Glioblastoma Organoid Culture and Drug Screening

Laboratory-Engineered Glioblastoma Organoid Culture and Drug Screening

Published on: January 10, 2025

Related Experiment Videos

Last Updated: Mar 8, 2026

Stereotactic Intracranial Implantation and In vivo Bioluminescent Imaging of Tumor Xenografts in a Mouse Model System of Glioblastoma Multiforme

Stereotactic Intracranial Implantation and In vivo Bioluminescent Imaging of Tumor Xenografts in a Mouse Model System of Glioblastoma Multiforme

Published on: September 25, 2012

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

Laboratory-Engineered Glioblastoma Organoid Culture and Drug Screening

Laboratory-Engineered Glioblastoma Organoid Culture and Drug Screening

Published on: January 10, 2025

Area of Science:

Neuro-oncology
Central Nervous System Tumors

Background:

Glioblastomas represent a significant challenge in neuro-oncology due to their aggressive nature.
Systematic recurrence and a poor prognosis are characteristic of glioblastoma.
Current treatment paradigms aim to balance survival extension with quality of life preservation.

Purpose of the Study:

To outline the standard treatment approaches for glioblastoma.
To emphasize the importance of supportive care in managing glioblastoma patients.

Main Methods:

This abstract summarizes established treatment protocols for glioblastoma.
It reviews the role of multimodal therapy including surgery, radiotherapy, and chemotherapy.
It highlights the necessity of symptomatic and supportive treatments.

Main Results:

Multimodal therapy including surgery, radiotherapy, and chemotherapy can prolong survival in glioblastoma patients.
Supportive and symptomatic treatments are crucial for maintaining patient quality of life.

Conclusions:

Glioblastoma treatment requires a comprehensive approach combining aggressive therapies with essential supportive care.
Optimizing quality of life remains a key objective alongside survival extension in glioblastoma management.